BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 22573484)

  • 1. The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled.
    Rowe PS
    Cell Biochem Funct; 2012 Jul; 30(5):355-75. PubMed ID: 22573484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
    Rowe PS
    Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.
    Liu S; Rowe PS; Vierthaler L; Zhou J; Quarles LD
    J Endocrinol; 2007 Jan; 192(1):261-7. PubMed ID: 17210763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.
    Martin A; David V; Laurence JS; Schwarz PM; Lafer EM; Hedge AM; Rowe PS
    Endocrinology; 2008 Apr; 149(4):1757-72. PubMed ID: 18162525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.
    David V; Martin A; Hedge AM; Drezner MK; Rowe PS
    Am J Physiol Renal Physiol; 2011 Mar; 300(3):F783-91. PubMed ID: 21177780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPR4-peptide alters bone metabolism of normal and HYP mice.
    Zelenchuk LV; Hedge AM; Rowe PS
    Bone; 2015 Mar; 72():23-33. PubMed ID: 25460577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin.
    Boukpessi T; Gaucher C; Léger T; Salmon B; Le Faouder J; Willig C; Rowe PS; Garabédian M; Meilhac O; Chaussain C
    Am J Pathol; 2010 Aug; 177(2):803-12. PubMed ID: 20581062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The wrickkened pathways of FGF23, MEPE and PHEX.
    Rowe PS
    Crit Rev Oral Biol Med; 2004 Sep; 15(5):264-81. PubMed ID: 15470265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage.
    Addison WN; Masica DL; Gray JJ; McKee MD
    J Bone Miner Res; 2010 Apr; 25(4):695-705. PubMed ID: 19775205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolism.
    Zelenchuk LV; Hedge AM; Rowe PS
    PLoS One; 2014; 9(5):e97326. PubMed ID: 24839967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM.
    Addison WN; Nakano Y; Loisel T; Crine P; McKee MD
    J Bone Miner Res; 2008 Oct; 23(10):1638-49. PubMed ID: 18597632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
    Martin A; Liu S; David V; Li H; Karydis A; Feng JQ; Quarles LD
    FASEB J; 2011 Aug; 25(8):2551-62. PubMed ID: 21507898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
    Martin A; David V; Li H; Dai B; Feng JQ; Quarles LD
    Mol Endocrinol; 2012 Nov; 26(11):1883-95. PubMed ID: 22930691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP).
    Rowe PS; Garrett IR; Schwarz PM; Carnes DL; Lafer EM; Mundy GR; Gutierrez GE
    Bone; 2005 Jan; 36(1):33-46. PubMed ID: 15664000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypophosphatemic rickets caused by a large deletion in PHEX gene.
    Saito T; Nishii Y; Yasuda T; Ito N; Suzuki H; Igarashi T; Fukumoto S; Fujita T
    Eur J Endocrinol; 2009 Oct; 161(4):647-51. PubMed ID: 19581284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia.
    Salmon B; Bardet C; Khaddam M; Naji J; Coyac BR; Baroukh B; Letourneur F; Lesieur J; Decup F; Le Denmat D; Nicoletti A; Poliard A; Rowe PS; Huet E; Vital SO; Linglart A; McKee MD; Chaussain C
    PLoS One; 2013; 8(2):e56749. PubMed ID: 23451077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
    Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic role of Fgf23 in Dmp1-null mice.
    Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets.
    Ruppe MD; Brosnan PG; Au KS; Tran PX; Dominguez BW; Northrup H
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):312-8. PubMed ID: 21050253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.